EAP Versus OLE Study

EAP VERSUS OLE Both an Open Label Extension (OLE) and an Expanded Access Program (EAP) can be used to provide continued treatment access after phase 3 clinical trials have ended. To help companies understand [...]

By |2024-02-01T12:01:23+00:00January 20th, 2021|

Sponsor Considerations for EAPs

SPONSOR CONSIDERATIONS FOR EAPs If your company is developing a drug that fulfils an unmet clinical need, you may have already started receiving patient enquiries about expanded access. We have put together this downloadable [...]

By |2024-02-01T12:02:29+00:00December 11th, 2020|

Expanded Access Policy Templates

EXPANDED ACCESS POLICY TEMPLATES If your company is developing a drug that fulfils an unmet clinical need, you may need an Expanded Access Policy on your website. We have provided three templates, one for each [...]

By |2024-02-01T12:02:15+00:00March 5th, 2020|
Go to Top